Vânia Almeidaa, Mamede de Carvalho*abc, Manuel Scottod, Susana Pintob, Anabela Pintobe, Benjamim Ohanabe & Michael Swashbfa Department of Neurosciences, Hospital de Santa Maria-CHLN, Lisbonb Neuromuscular Unit, Instituto de Medicina Molecular − Faculty of Medicine of Lisbonc Institute of Physiology, Faculty of Medicine of Lisbond Department of Mathematics, University of Aveiro, Aveiro, Portugale Department of Medical Rehabilitation, Hospital de Santa Maria-CHLN, Lisbon, Portugalf Department of Neurology, Royal London Hospital, Queen Mary School of Medicine, University of London, London, UKCorrespondence: M. de Carvalho, Department of Neurosciences, Hospital da Santa Maria, Av. Prof. Egas Moniz, 1649-035 Lisboa, Portugal. Fax: +351217805219. E-mail: mamedemg@mail.telepac.ptAbstractOur objective was to investigate functional outcome in primary lateral sclerosis (PLS). We followed a group of 24 patients with PLS. Clinical (ALSFRS), respiratory, and neurophysiological (electromyography and transcranial magnetic stimulation) evaluations were performed at entry and regularly over the follow-up period. The time taken for a greater than 10% decrease in ALSFRS compared to the first assessment was defined as the dichotomous outcome; prognostic factors were evaluated using the Cox proportional hazard model. Results demonstrated that the median age at symptom onset was 54 years (range 28−75 years). In 46% symptoms began in the lower limbs, in 21% in the upper limbs and in 33% in bulbar muscles. The median symptom duration at first visit was 3.1 years (range 0.9−11.7 years). At last follow-up the median disease duration was 9.9 years (range 4.2−17.6 years). The median follow-up time was 4.6 years (range 2.1−11 years). We excluded from final analysis three patients with positive family history. Older age at onset (p = 0.019) was related to more rapid functional impairment; gender, forced vital capacity, region of onset and neurophysiological changes did not predict outcome. In conclusion, age is the most critical prognostic factor for functional outcome in PLS.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: